Revance Therapeutics, Inc (RVNC) Covered Calls

Revance Therapeutics, Inc covered calls Revance Therapeutics Inc is a clinical stage specialty biopharmaceutical company, engaged in the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

You can sell covered calls on Revance Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RVNC (prices last updated Fri 4:16 PM ET):

Revance Therapeutics, Inc (RVNC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
19.91 -0.79 19.91 25.65 321K - 0.0B
Covered Calls For Revance Therapeutics, Inc (RVNC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 20 0.45 25.20 -20.6% -939.9%
Jan 18 20 0.95 24.70 -19.0% -192.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Revance Therapeutics, Inc. is a clinical stage specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The company was founded by Jacob M. Waugh and L. Daniel Browne in August 10, 1999 and is headquartered in Newark, CA.